Concepedia
Statistics
Publications
13
Citations
320
H-Index
Active since
2008
Affiliations
Karl Landsteiner University of Health Sciences(Current)
Medical University of Vienna
Universitätsklinikum Krems
Otto Wagner Hospital
Medical University of Graz
Peter Errhalt is an author at Karl Landsteiner University of Health Sciences specializing in medicine, oncology, and lung cancer.
Publications per year
2008–2024
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC
Anna Buder, Maximilian J. Hochmair, Sophia Schwab et al. · Journal of Thoracic Oncology · 2018 · 66 citations · Full text
Medicine, Oncology, Pharmacotherapy +9
Canine scent detection for the diagnosis of lung cancer in a screening-like situation
Klaus Hackner, Peter Errhalt, Michael Rolf Mueller et al. · Journal of Breath Research · 2016 · 48 citations
Medicine, Oncology, Cancer Prevention +10
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
Klaus Hackner, Peter Errhalt, Sabin Handzhiev · Therapeutic Advances in Medical Oncology · 2019 · 30 citations · Full text
Medicine, Oncology, Pathology +17
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
Maximilian J. Hochmair, Hannah Fabikan, Oliver Illini et al. · Pharmaceuticals · 2020 · 30 citations · Full text
Medicine, Oncology, Pharmacology +15
Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers
Ilka Steiner, Peter Errhalt, Klaus Kubesch et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 28 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
1–5 of 13